PT Itama Ranoraya TbkISX:IRRA 81 Gross Margin % is 23.29% as of Mar. 2026, which is 10% above its 10-year median of 21.11. GuruFocus rates ISX:IRRA with a GF Score™ of 81/100 and a GF Value™ of Rp535.49 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 116 Medical Distribution companies, PT Itama Ranoraya Tbk ranks better than 62.93% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PT Itama Ranoraya Tbk had a gross margin of 23.29% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PT Itama Ranoraya Tbk Gross Margin % Related Terms
PT Itama Ranoraya Tbk Gross Margin % Historical Data
* Premium members only.
The historical data trend for PT Itama Ranoraya Tbk's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:IRRA vs MCK, CAH, COR: Gross Margin % Comparison
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PT Itama Ranoraya Tbk (ISX:IRRA) has a Gross Margin % of 23.29% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Itama Ranoraya Tbk and its competitors. This is 10% above median its historical median of 21.11. Over the past decade, PT Itama Ranoraya Tbk's Gross Margin % has ranged from 17.88 to 24.36. According to the industry distribution chart, PT Itama Ranoraya Tbk ranks #43 out of 116 companies in the Medical Distribution industry, placing it in the top 37.1%.
Is PT Itama Ranoraya Tbk's Gross Margin % too high?
PT Itama Ranoraya Tbk's current Gross Margin % of 23.29% is 10% above median its 10-year median of 21.11. Over the past 10 years, this metric has ranged from a low of 17.88 to a high of 24.36. The Medical Distribution industry median Gross Margin % is 14.90. PT Itama Ranoraya Tbk's value of 23.29% is 56.3% above this industry median. Based on the distribution chart, PT Itama Ranoraya Tbk ranks #43 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Gross Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Itama Ranoraya Tbk ranks #43 out of 116 companies for Gross Margin %. This puts PT Itama Ranoraya Tbk in the upper half of its industry. The industry median Gross Margin % is 14.90. PT Itama Ranoraya Tbk's value of 23.29% is 56.3% above this benchmark. Historically, PT Itama Ranoraya Tbk's own Gross Margin % has ranged from 17.88 to 24.36 over the past decade. While the company's 10-year median is 21.11 vs. the industry median of 14.90, PT Itama Ranoraya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Itama Ranoraya Tbk's current Gross Margin % of 23.29% is 56.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Itama Ranoraya Tbk and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Itama Ranoraya Tbk's current Gross Margin % is 23.29%, which is 10% above median its own 10-year median of 21.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp535.49, compared to a current price of Rp374.00 — trading 30.2% below its estimated fair value. The current Gross Margin % is 23.29%, which is 10% above median its 10-year median of 21.11 and 56.3% above the Medical Distribution industry median of 14.90. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Gross Margin % is 23.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp374.00 is trading 30.2% below its estimated GF Value™ of Rp535.49.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Gross Margin %: 23.29% (10% above median its 10-year median of 21.11)
GF Value™: Rp535.49 vs. price of Rp374.00 (30.2% below fair value)
Industry Position: 56.3% above the Medical Distribution median (#43 of 116)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
